Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 11
Submit an article Journal homepage
912
Views
14
CrossRef citations to date
0
Altmetric
AUTHOR'S VIEW

Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients

Yoshihiro OhueDepartment of Respiratory Medicine; Kawasaki Medical School; Kurashiki, Japan
,
Hisashi WadaDepartment of Clinical Research in Tumor Immunology; Graduate School of Medicine; Osaka University; Suita, Japan
,
Mikio OkaDepartment of Respiratory Medicine; Kawasaki Medical School; Kurashiki, Japan
&
Eiichi NakayamaFaculty of Health and Welfare; Kawasaki University of Medical Welfare; Kurashiki, JapanCorrespondence[email protected]
Article: e970032 | Received 21 Sep 2014, Accepted 23 Sep 2014, Published online: 10 Dec 2014

References

  • Gnjatic S, Nishikawa H, Jungbluth AA, Güre AO, Ritter G, Jäger E, Knuth A, Chen YT, Old LJ. NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res 2006; 95:1-30; PMID:16860654; http://dx.doi.org/10.1016/S0065-230X(06)95001-5
  • Tsuji T, Matsuzaki J, Ritter E, Miliotto A, Ritter G, Odunsi K, Old LJ, Gnjatic S. Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors. PLoS One 2011; 6:e23651; PMID:21858191; http://dx.doi.org/10.1371/journal.pone.0023651
  • Fujiwara S, Wada H, Kawada J, Kawabata R, Takahashi T, Fujita J, Hirao T, Shibata K, Makari Y, Iijima S, et al. NY-ESO-1 antibody as a novel tumor marker of gastric cancer. Br J Cancer 2013; 108:1119-1125, PMID:23403818; http://dx.doi.org/10.1038/bjc.2013.51
  • Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ, et al. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res 2005; 11:8055-8062, PMID:16299236; http://dx.doi.org/10.1158/1078-0432.CCR-05-1203
  • Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, Fukuda M, Uenaka A, Oka M, Nakayama E. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res 2014; pii: clincanres.0742. [Epub ahead of print]; PMID:25124687; http://dx.doi.org/10.1158/1078-0432.CCR-14-0742
  • Daudi S, Eng KH, Mhawech-Fauceglia P, Morrison C, Miliotto A, Beck A, Matsuzaki J, Tsuji T, Groman A, Gnjatic S, et al. Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer. PLoS One 2014; 9:e104099, PMID:25101620; http://dx.doi.org/10.1371/journal.pone.0104099
  • Müller M, Meyer M, Schilling T, Ulsperger E, Lehnert T, Zentgraf H, Stremmel W, Volkmann M, Galle PR. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers. Int J Oncol 2006; 29:973-980, PMID:16964393; http://dx.doi.org/10.3892/ijo.29.4.973
  • Weide B, Martens A, Zelba H, Stutz C, Derhovanessian E, Di Giacomo AM, Maio M, Sucker A, Schilling B, Schadendorf D, et al. Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells. Clin Cancer Res 2014; 20:1601-1609, PMID:24323899; http://dx.doi.org/10.1158/1078-0432.CCR-13-2508
  • Tanchot C, Terme M, Pere H, Tran T, Benhamouda N, Strioga M, Banissi C, Galluzzi L, Kroemer G, Tartour E. Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenviron 2013; 6:147-157, PMID:23104434; http://dx.doi.org/10.1007/s12307-012-0122-y
  • Pandey JP, Namboodiri AM, Ohue Y, Oka M, Nakayama E. Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer. Clin Exp Immunol 2014; 176:78-83, PMID:24304136; http://dx.doi.org/10.1111/cei.12247

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.